Results
|
1.
|
Effect of Bleeding Risk on Type of Stent Used in Patients Presenting With Acute Coronary Syndrome. MedStar authors:
- Alraies, M Chadi
- Ben-Dor, Itsik
- Buchanan, Kyle
- Gai, Jiaxiang
- Koifman, Edward
- Lee, Sang Yeub
- Lipinski, Michael J
- Pichard, Augusto D
- Rogers, Toby
- Satler, Lowell F
- Steinvil, Arie
- Torguson, Rebecca
- Waksman, Ron
Year: 2017
Citation: - American Journal of Cardiology. 120(8):1272-1278, 2017 Oct 15
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alraies MC, Ben-Dor I, Buchanan K, Gai J, Koifman E, Lee SY, Lipinski MJ, Pichard AD, Rogers T, Satler LF, Steinvil A, Torguson R, Waksman R
|
|
2.
|
Artificially sweetened beverages, sugar-sweetened beverages, plain water, and incident diabetes mellitus in postmenopausal women: the prospective Women's Health Initiative observational study. MedStar authors:
Year: 2017
Citation: - American Journal of Clinical Nutrition. 106(2):614-622, 2017 Aug
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Eaton CB, Howard BV, Huang M, Kutob RM, Lu B, Manson JE, Quddus A, Shikany JM, Stinson L
|
|
3.
|
|
|
4.
|
A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women's Health Initiative Dietary Modification Trial. MedStar authors:
Year: 2017
Citation: - Diabetes Care. 41(4):680-687, 2018 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Allison M, Aragaki AK, Hingle MD, Howard BV, Johnson KC, Manson JE, Prentice RL, Shadyab AH, Shikany JM, Snetselaar LG, Thomson CA, Tinker LF, Zaslavsky O
|
|
5.
|
|
|
6.
|
|
|
7.
|
Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors:
Year: 2017
Citation: - Diabetic Medicine. 34(12):1747-1755, 2017 Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group
|
|
8.
|
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. MedStar authors:
Year: 2017
Citation: - Clinical Transplantation. 31(5), 2017 May
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Hassan M, Lalos A, Liriano-Ward L, Morales AL, Nair V, Sang M, Satoskar R, Schiano T, Smith C, Tierney A
|